Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara M Tolaney

Showing results (31-40 of 372) with videos related to

Pageof 38
Sort By:
JAMA Oncology|November 3, 2022
Association of Hormone Receptors With Clinical Outcomes in Patients With ERBB2-Low Breast Cancer-ReplyPaolo Tarantino, Nabihah Tayob, Sara M Tolaney
Clinical Advances in Hematology & Oncology : H&O|June 13, 2019
How we treat locally advanced HER2-positive breast cancerPedro Exman, Sonia Pernas, Sara M Tolaney
Cancers|August 26, 2022
Overcoming Resistance to HER2-Directed Therapies in Breast CancerIlana Schlam, Paolo Tarantino, Sara M Tolaney
Endocrine-Related Cancer|September 5, 2024
Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple-negative breast cancer patientsMarta Villanova, Sara M Tolaney, Le Min
Breast (Edinburgh, Scotland)|January 20, 2023
How I treat HER2-low advanced breast cancerIlana Schlam, Sara M Tolaney, Paolo Tarantino
Expert Opinion on Drug Safety|November 23, 2023
Interstitial lung disease and CDK4/6 inhibitors in the treatment of breast cancerIlana Schlam, Antonio Giordano, Sara M Tolaney
Expert Opinion on Biological Therapy|October 6, 2023
Managing adverse events of sacituzumab govitecanIlana Schlam, Paolo Tarantino, Sara M Tolaney
Cancer Discovery|July 20, 2022
Navigating the HER2-Low Paradigm in Breast Oncology: New Standards, Future HorizonsPaolo Tarantino, Giuseppe Curigliano, Sara M Tolaney
JAMA Oncology|September 22, 2022
Etirinotecan Pegol Treatment for Patients With Metastatic Breast Cancer and Brain Metastases-ReplyDebu Tripathy, Sara M Tolaney, Mary Tagliaferri
Expert Review of Anticancer Therapy|January 24, 2023
The efficacy of trastuzumab-deruxtecan for the treatment of patients with advanced HER2-low breast cancerIlana Schlam, Sara M Tolaney, Paolo Tarantino
Pageof 38

Showing results (31-40 of 372) with videos related to

Sort By:
Pageof 38
JAMA Oncology|November 3, 2022
Association of Hormone Receptors With Clinical Outcomes in Patients With ERBB2-Low Breast Cancer-ReplyPaolo Tarantino, Nabihah Tayob, Sara M Tolaney
Clinical Advances in Hematology & Oncology : H&O|June 13, 2019
How we treat locally advanced HER2-positive breast cancerPedro Exman, Sonia Pernas, Sara M Tolaney
Cancers|August 26, 2022
Overcoming Resistance to HER2-Directed Therapies in Breast CancerIlana Schlam, Paolo Tarantino, Sara M Tolaney
Endocrine-Related Cancer|September 5, 2024
Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple-negative breast cancer patientsMarta Villanova, Sara M Tolaney, Le Min
Breast (Edinburgh, Scotland)|January 20, 2023
How I treat HER2-low advanced breast cancerIlana Schlam, Sara M Tolaney, Paolo Tarantino
Expert Opinion on Drug Safety|November 23, 2023
Interstitial lung disease and CDK4/6 inhibitors in the treatment of breast cancerIlana Schlam, Antonio Giordano, Sara M Tolaney
Expert Opinion on Biological Therapy|October 6, 2023
Managing adverse events of sacituzumab govitecanIlana Schlam, Paolo Tarantino, Sara M Tolaney
Cancer Discovery|July 20, 2022
Navigating the HER2-Low Paradigm in Breast Oncology: New Standards, Future HorizonsPaolo Tarantino, Giuseppe Curigliano, Sara M Tolaney
JAMA Oncology|September 22, 2022
Etirinotecan Pegol Treatment for Patients With Metastatic Breast Cancer and Brain Metastases-ReplyDebu Tripathy, Sara M Tolaney, Mary Tagliaferri
Expert Review of Anticancer Therapy|January 24, 2023
The efficacy of trastuzumab-deruxtecan for the treatment of patients with advanced HER2-low breast cancerIlana Schlam, Sara M Tolaney, Paolo Tarantino
Pageof 38